Infusion is a technique through which fluids and certain therapeutic drugs can be administered to patients either subcutaneously, arterially, intravenously, or peritoneally. An infusion pump, a specially designed medical device, makes infusions safe and precise. The sheer increase in the number of people suffering from chronic diseases, those undergoing surgeries, or other medical treatments, has pushed up sales of infusion pumps worldwide.
Interpret a Competitive Outlook Analysis Report with PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1601
This report studies the state of the global infusion pumps market and tracks present developments to create projections for the growth of the market in the coming years. The forecasting horizon of the report spans from 2013 to 2019. In order to study the global infusion pumps market at multiple levels, the authors of the report have segmented the market into sub-markets on the basis of criteria such as application and geography. A holistic competitive study of the market has also been undertaken to help companies understand their current standing in the global infusion pumps market and compare their strategies against those of others in the market.
Revenue is expressed in US$ mn whereas growth has been expressed in CAGR (%). The authors of the report have taken 2011 as a historical year and the base year for the study is 2012.
The global infusion pumps market, which stood at approximately US$5.41 bn in 2012, is projected to exhibit a steady CAGR of 5.3%, and rise in valuation to US$ 7.76 bn by 2019. With an alarming increase in the number of people diagnosed with cancer, diabetes, chronic pain, and other conditions and disease, the need to demand for medical devices that can administer drugs in precise dosages to treat such conditions has seen an uptick. The global infusion pumps market has benefited immensely from this and is expected to do so in the next four years as well.
As the drug delivery process becomes increasingly automated, ‘smart’ infusion pumps are making their presence conspicuously felt on the market. Patients are expected to opt for more smart pumps in the future as they look for less painful, yet more accurate, safe, and convenient drug delivery systems. The trend of home-based healthcare will provide an additional thrust to infusion pump sales. However, the market has suffered a blow in recent years owing to product recalls, which have put several companies’ reputation at stake. Manufacturing defect-free and rigorously tested infusion pumps has thus become central to sustaining a profitable presence in the global infusion pumps market.
The demand for large volume infusion pumps has thus far been the highest, and is expected to remain so. Disposable infusion pumps have seen an appreciable share in the global infusion pumps market by product type, but will still continue to trail the large-volume infusion pumps market in terms of sales in the near future. Infusion pumps have been most extensively used for administering clinical nutrition. In the coming years, the demand for infusion pumps during cancer treatments and analgesia will rise.
While North America constitutes the largest infusion pumps market globally, the rise of the Asia Pacific region will be worth watching out, especially with massive demand expected to be seen in India and China.
The report profiles the following companies in the global infusion pumps market: Hospira, Inc., CareFusion Corporation, Baxter International, Inc., B. Braun Melsungen AG, Fresenius Kabi AG, and Terumo Corporation.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453